118 related articles for article (PubMed ID: 14470783)
1. [On the problem of the method of determination of properdin in human serum by the zymosan method].
MASHKOV AV; MIKHAILOVA ZM
Zh Mikrobiol Epidemiol Immunobiol; 1962 May; 33():103-8. PubMed ID: 14470783
[No Abstract] [Full Text] [Related]
2. [The usefulness of various zymosan preparations in determination of properdin].
von GRAEVENITZ ; HUSMANN KH; HOEBBEL K
Med Exp Int J Exp Med; 1960; 3():230-6. PubMed ID: 13707673
[No Abstract] [Full Text] [Related]
3. [On the possibility of determination of blood properdin by means of zymosan in the serums of different animal species].
MAZZEI D; TASCHINI P
Policlinico Med; 1959; 66():391-401. PubMed ID: 13853881
[No Abstract] [Full Text] [Related]
4. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
BLUM L; PILLEMER L; LEPOW IH
Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
[No Abstract] [Full Text] [Related]
5. [Properdin system and its role in infection and immunity. II. Determination of biological activities of zymosan].
ANDREEVA ZM; NIKITINA VD
Zh Mikrobiol Epidemiol Immunobiol; 1960 Nov; 31():49-53. PubMed ID: 13683406
[No Abstract] [Full Text] [Related]
6. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
[No Abstract] [Full Text] [Related]
7. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
SZABO IK
Orv Hetil; 1960 Feb; 101():222-5. PubMed ID: 13836258
[No Abstract] [Full Text] [Related]
8. [Influence of subcutaneously and intramuscularly administered zymosan on the properdin titer of serum and on leukocyte count in animal experiments].
ZSEBOK Z; WACHTL I; SZY S; SELLEI G
Orv Hetil; 1960 Feb; 101():226-9. PubMed ID: 13847797
[No Abstract] [Full Text] [Related]
9. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
HINZ CF; WEDGWOOD RJ; PILLEMER L
J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
[No Abstract] [Full Text] [Related]
10. Anaphylactic shock in zymosan pre-treated guinea-pigs. (A study on the possible role of properdin)].
WILHELM RE; SALVAGGIO J; KRUPP I
Int Arch Allergy Appl Immunol; 1961; 18():318-29. PubMed ID: 13831364
[No Abstract] [Full Text] [Related]
11. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
FUMAROLA D; MODICA F
Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
[No Abstract] [Full Text] [Related]
12. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
HERBUT PA; KRAEMER WH
Cancer Res; 1956 Dec; 16(11):1048-52. PubMed ID: 13383472
[No Abstract] [Full Text] [Related]
13. [Relation between zymosan, properdin & tumors. I. Effect of zymosan on the development of benzpyrene-induced sarcomas].
MODICA F
Tumori; 1958; 44(6):538-48. PubMed ID: 13635872
[No Abstract] [Full Text] [Related]
14. Studies on the mechanism of properdin--zymosan reaction. The role of polysaccharide structure in combination with properdin.
CSEH G; SZABO I
Acta Microbiol Acad Sci Hung; 1961; 8():181-7. PubMed ID: 13718704
[No Abstract] [Full Text] [Related]
15. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
LEON MA
J Exp Med; 1957 May; 105(5):403-15. PubMed ID: 13428911
[TBL] [Abstract][Full Text] [Related]
16. Further studies on cytolysis of Ehrlich ascites tumor cells brought into contact with normal human serum. The nature of the heat-labile factor.
TOKUNAGA A; OKAMURA J; KOSAKI G; KURU M
Gan; 1962 Jun; 53():145-58. PubMed ID: 13921595
[No Abstract] [Full Text] [Related]
17. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.
LANDY M; PILLEMER L
J Exp Med; 1956 Jun; 103(6):823-33. PubMed ID: 13319594
[TBL] [Abstract][Full Text] [Related]
18. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE.
BLUM L
J Immunol; 1964 Jan; 92():61-72. PubMed ID: 14139548
[No Abstract] [Full Text] [Related]
19. Adaptation of the zymosan assay of properdin to animal sera.
KENT JF; TOUSSAINT AJ; HOOK WA
Proc Soc Exp Biol Med; 1957 Dec; 96(3):676-8. PubMed ID: 13505826
[No Abstract] [Full Text] [Related]
20. Alterations in serum lysozyme and properdin titers of mice following x-irradiation or treatment with zymosan or endotoxin.
HOOK WA; CAREY WF; MUSCHEL LH
J Immunol; 1960 Jun; 84():569-75. PubMed ID: 14402997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
